RIP kinase inhibitor GSK963, Purity ≥98%

Cat. No.: X23-10-ZQ178

RIP kinase inhibitor GSK963, Purity ≥98%

Synonym: 2049868-46-2; GSK963; GSK-963; GSK'963; (S)-2,2-Dimethyl-1-(5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)propan-1-one; RIP kinase inhibitor

  • CAS Number: 2049868-46-2
  • Compound CID: 122703613
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
GSK963, soluble in DMSO and ethanol and insoluble in water, is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.
Molecular Weight
230.311
Molecular Formula
C14H18N2O
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 41 mg/mL (178.02 mM); Water: Insoluble; Ethanol: 41 mg/mL (178.02 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
GSK963 can be used to investigate RIPK1 inhibition and its implications in inflammation and cell death.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0